Ahmed T - Search Results

1

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.

Puccio CA, Mittelman A, Lichtman SM, Silver RT, Budman DR, Ahmed T, Feldman EJ, Coleman M, Arnold PM, Arlin ZA, et al. Puccio CA, et al. Among authors: ahmed t. J Clin Oncol. 1991 Sep;9(9):1562-9. doi: 10.1200/JCO.1991.9.9.1562. J Clin Oncol. 1991. PMID: 1714949 Clinical Trial.

2

A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion.

Mittelman A, Puccio C, Gafney E, Coombe N, Singh B, Wood D, Nadler P, Ahmed T, Arlin Z. Mittelman A, et al. Among authors: ahmed t. Invest New Drugs. 1992 Aug;10(3):183-90. doi: 10.1007/BF00877244. Invest New Drugs. 1992. PMID: 1428728 Clinical Trial.

3

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: ahmed t. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

4

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer.

Mittelman A, Savona S, Puccio C, Chun H, Ahmed T, Feldman E, Sullivan P, Arnold P, Arlin Z. Mittelman A, et al. Among authors: ahmed t. Invest New Drugs. 1990;8 Suppl 1:S65-7. doi: 10.1007/BF00171986. Invest New Drugs. 1990. PMID: 1696246

5

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.

Arlin ZA, Feldman EJ, Finger LR, Ahmed T, Mittelman A, Cook P, Puccio C, Baskind P, Arnold P, Razis ED, et al. Arlin ZA, et al. Among authors: ahmed t. Leukemia. 1991 Aug;5(8):712-4. Leukemia. 1991. PMID: 1886423

6

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer.

Mittelman A, Ashikari R, Ahmed T, Savona S, Arnold P, Arlin Z. Mittelman A, et al. Among authors: ahmed t. Cancer Chemother Pharmacol. 1988;22(1):63-4. doi: 10.1007/BF00254183. Cancer Chemother Pharmacol. 1988. PMID: 2456162

7

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults.

Arlin ZA, Feldman E, Kempin S, Ahmed T, Mittelman A, Savona S, Ascensao J, Baskind P, Sullivan P, Fuhr HG, Mertelsmann R. Arlin ZA, et al. Among authors: ahmed t. Blood. 1988 Aug;72(2):433-5. Blood. 1988. PMID: 3165293 Free article.

8

A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia.

Arlin ZA, Ahmed T, Mittelman A, Feldman E, Mehta R, Weinstein P, Rieber E, Sullivan P, Baskind P. Arlin ZA, et al. Among authors: ahmed t. J Clin Oncol. 1987 Mar;5(3):371-5. doi: 10.1200/JCO.1987.5.3.371. J Clin Oncol. 1987. PMID: 3546613 Clinical Trial.

9

Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.

Ahmed T, Cook P, Feldman E, Coombe N, Puccio C, Mittelman A, Chun H, Coleman M, Helson L. Ahmed T, et al. Leukemia. 1994 Apr;8(4):531-4. Leukemia. 1994. PMID: 8152247 Clinical Trial.

10

Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.

Feldman EJ, Alberts DS, Arlin Z, Ahmed T, Mittelman A, Baskind P, Peng YM, Baier M, Plezia P. Feldman EJ, et al. Among authors: ahmed t. J Clin Oncol. 1993 Oct;11(10):2002-9. doi: 10.1200/JCO.1993.11.10.2002. J Clin Oncol. 1993. PMID: 8410125 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,876 results

Search Page

Filters